Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study

Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study

B Ditz,1,2 LEM Kistemaker,2– 4 M van den Berge,1,2 JM Vonk,2,5 R Gosens,2,3 HAM Kerstjens1,2 1Department of Pulmonary Diseases, University Medical Center, University of Groningen, Groningen, the Netherlands; 2Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Univ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ditz B, Kistemaker LEM, van den Berge M, Vonk JM, Gosens R, Kerstjens HAM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
copd
exacerbation
induced sputum
cytokines
mrna and protein levels
Diseases of the respiratory system
RC705-779
Acceso en línea:https://doaj.org/article/1978bbcb3a614215800f9ba29702746c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1978bbcb3a614215800f9ba29702746c
record_format dspace
spelling oai:doaj.org-article:1978bbcb3a614215800f9ba29702746c2021-11-09T18:40:35ZResponsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study1178-2005https://doaj.org/article/1978bbcb3a614215800f9ba29702746c2021-11-01T00:00:00Zhttps://www.dovepress.com/responsivity-and-reproducibility-of-sputum-inflammatory-biomarkers-dur-peer-reviewed-fulltext-article-COPDhttps://doaj.org/toc/1178-2005B Ditz,1,2 LEM Kistemaker,2– 4 M van den Berge,1,2 JM Vonk,2,5 R Gosens,2,3 HAM Kerstjens1,2 1Department of Pulmonary Diseases, University Medical Center, University of Groningen, Groningen, the Netherlands; 2Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 3Department of Molecular Pharmacology of Groningen, University of Groningen, Groningen, the Netherlands; 4Aquilo BV, Groningen, the Netherlands; 5Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsCorrespondence: HAM KerstjensDepartment of Pulmonary Diseases, University Medical Center, University of Groningen, Groningen, the NetherlandsEmail h.a.m.kerstjens@umcg.nlIntroduction: There is a great interest to identify airway biomarkers to evaluate the potential and efficacy of anti-inflammatory therapeutic interventions. In this pilot study, we compared cytokine mRNA and protein levels of IL-6, IL-8, CCL2, CCL4, and TNF-α, as well as LTB-4 expression regarding their reproducibility and responsivity in induced sputum in COPD patients.Methods: We recruited a cohort of 17 patients with a moderate COPD exacerbation, necessitating antibiotics and/or oral corticosteroids. Patients were followed for two consecutive stable phase visits. Cytokine mRNA and protein levels were measured in induced sputum samples.Results: IL-6 and CCL4 protein levels decreased from exacerbation to stable phase, whereas their mRNA expression showed the same trend (not statistically significant). Coefficients of variation were overall lower (ie, more favorable for responsiveness) at protein levels compared to mRNA levels. No significant differences were observed in the reproducibility between cytokine mRNA expression and protein measurements. IL-6, IL-8, CCL2, and TNF-α gene expression levels yielded moderate to high intraclass correlation coefficients and/or Spearman correlation coefficients between both stable phase samples in contrast to their protein levels.Conclusion: Our findings suggest that several protein levels yield better responsivity with lower noise-to-signal ratios compared to their respective mRNA levels. In contrast, cytokine mRNA expression was more reproducible as it varied less in a stable state than proteins. Future studies are needed with a larger sample size to further evaluate the differences of responsivity and reproducibility between cytokine mRNA and protein measurements, not only during exacerbations.Keywords: COPD, exacerbation, induced sputum, cytokines, mRNA and protein levelsDitz BKistemaker LEMvan den Berge MVonk JMGosens RKerstjens HAMDove Medical Pressarticlecopdexacerbationinduced sputumcytokinesmrna and protein levelsDiseases of the respiratory systemRC705-779ENInternational Journal of COPD, Vol Volume 16, Pp 3055-3064 (2021)
institution DOAJ
collection DOAJ
language EN
topic copd
exacerbation
induced sputum
cytokines
mrna and protein levels
Diseases of the respiratory system
RC705-779
spellingShingle copd
exacerbation
induced sputum
cytokines
mrna and protein levels
Diseases of the respiratory system
RC705-779
Ditz B
Kistemaker LEM
van den Berge M
Vonk JM
Gosens R
Kerstjens HAM
Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
description B Ditz,1,2 LEM Kistemaker,2– 4 M van den Berge,1,2 JM Vonk,2,5 R Gosens,2,3 HAM Kerstjens1,2 1Department of Pulmonary Diseases, University Medical Center, University of Groningen, Groningen, the Netherlands; 2Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 3Department of Molecular Pharmacology of Groningen, University of Groningen, Groningen, the Netherlands; 4Aquilo BV, Groningen, the Netherlands; 5Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsCorrespondence: HAM KerstjensDepartment of Pulmonary Diseases, University Medical Center, University of Groningen, Groningen, the NetherlandsEmail h.a.m.kerstjens@umcg.nlIntroduction: There is a great interest to identify airway biomarkers to evaluate the potential and efficacy of anti-inflammatory therapeutic interventions. In this pilot study, we compared cytokine mRNA and protein levels of IL-6, IL-8, CCL2, CCL4, and TNF-α, as well as LTB-4 expression regarding their reproducibility and responsivity in induced sputum in COPD patients.Methods: We recruited a cohort of 17 patients with a moderate COPD exacerbation, necessitating antibiotics and/or oral corticosteroids. Patients were followed for two consecutive stable phase visits. Cytokine mRNA and protein levels were measured in induced sputum samples.Results: IL-6 and CCL4 protein levels decreased from exacerbation to stable phase, whereas their mRNA expression showed the same trend (not statistically significant). Coefficients of variation were overall lower (ie, more favorable for responsiveness) at protein levels compared to mRNA levels. No significant differences were observed in the reproducibility between cytokine mRNA expression and protein measurements. IL-6, IL-8, CCL2, and TNF-α gene expression levels yielded moderate to high intraclass correlation coefficients and/or Spearman correlation coefficients between both stable phase samples in contrast to their protein levels.Conclusion: Our findings suggest that several protein levels yield better responsivity with lower noise-to-signal ratios compared to their respective mRNA levels. In contrast, cytokine mRNA expression was more reproducible as it varied less in a stable state than proteins. Future studies are needed with a larger sample size to further evaluate the differences of responsivity and reproducibility between cytokine mRNA and protein measurements, not only during exacerbations.Keywords: COPD, exacerbation, induced sputum, cytokines, mRNA and protein levels
format article
author Ditz B
Kistemaker LEM
van den Berge M
Vonk JM
Gosens R
Kerstjens HAM
author_facet Ditz B
Kistemaker LEM
van den Berge M
Vonk JM
Gosens R
Kerstjens HAM
author_sort Ditz B
title Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
title_short Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
title_full Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
title_fullStr Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
title_full_unstemmed Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
title_sort responsivity and reproducibility of sputum inflammatory biomarkers during copd exacerbation and stable phases – a pilot study
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/1978bbcb3a614215800f9ba29702746c
work_keys_str_mv AT ditzb responsivityandreproducibilityofsputuminflammatorybiomarkersduringcopdexacerbationandstablephasesndashapilotstudy
AT kistemakerlem responsivityandreproducibilityofsputuminflammatorybiomarkersduringcopdexacerbationandstablephasesndashapilotstudy
AT vandenbergem responsivityandreproducibilityofsputuminflammatorybiomarkersduringcopdexacerbationandstablephasesndashapilotstudy
AT vonkjm responsivityandreproducibilityofsputuminflammatorybiomarkersduringcopdexacerbationandstablephasesndashapilotstudy
AT gosensr responsivityandreproducibilityofsputuminflammatorybiomarkersduringcopdexacerbationandstablephasesndashapilotstudy
AT kerstjensham responsivityandreproducibilityofsputuminflammatorybiomarkersduringcopdexacerbationandstablephasesndashapilotstudy
_version_ 1718440816256483328

Ejemplares similares